Ulipristal acetate, a treatment for uterine fibroids and an emergency contraceptive, can be used in combination with misoprostol as part of a medication abortion regimen, according to a proof-of ...

If you need to fly with medication, you may have a moment of panic while packing, wondering whether you can take pills or liquid or injectable medicines on a plane or travel with prescription ...

If you’re looking to build your first monthly budget, or want to revise ... ve spent time tracking your spending, it’s time to review your spending history and how it aligns with your ...

A ulipristal-misoprostol medication regimen successfully terminated pregnancies in 97% of women. The findings suggest ulipristal-misoprostol could serve as an alternative to mifepristone.

“A new non-opioid analgesic therapeutic class for acute pain offers an opportunity to mitigate certain risks associated with using an opioid for pain and provides patients with another treatment ...

The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment ... drug’s development and review underscore FDA ...

Vertex Pharmaceuticals Vertex's medication ... patients with another treatment option. This action and the agency's designations to expedite the drug's development and review underscore FDA's ...

Fortunately, as Matthew Herfield, co-founder and CEO of BuzzRx, a prescription savings service, explains, resources such as BuzzRx can help lower monthly prescription medication expenses and offer ...

They work to reduce stomach acid, which helps ease acid reflux symptoms. Histamine-2 (H2) blockers, also called H2-receptor antagonists, are another OTC acid reflux medication. They work by binding to ...

This includes oral (by mouth), enteral (into the gastrointestinal tract), mucosal (through a mucus membrane), and percutaneous (through the skin). Administration routes are based on the medication ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...

In response to these favorable outcomes, it was decided to discontinue the medication, transitioning the patient to a monitoring phase. During the one-month clinical follow-up, the patient’s condition ...